Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.

Applebaum MA, Barr EK, Karpus J, Nie J, Zhang Z, Armstrong AE, Uppal S, Sukhanova M, Zhang W, Chlenski A, Salwen HR, Wilkinson E, Dobratic M, Grossman R, Godley LA, Stranger BE, He C, Cohn SL.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00402. Epub 2019 May 16.

2.

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.

Chlenski A, Park C, Dobratic M, Salwen HR, Budke B, Park JH, Miller R, Applebaum MA, Wilkinson E, Nakamura Y, Connell PP, Cohn SL.

Mol Cancer Ther. 2019 Mar;18(3):507-516. doi: 10.1158/1535-7163.MCT-18-0819. Epub 2019 Jan 23.

PMID:
30674566
3.

Microsurgery Competency During Plastic Surgery Residency: An Objective Skills Assessment of an Integrated Residency Training Program.

Applebaum MA, Doren EL, Ghanem AM, Myers SR, Harrington M, Smith DJ.

Eplasty. 2018 Sep 25;18:e25. eCollection 2018.

4.

Genetic Predisposition to Neuroblastoma.

Barr EK, Applebaum MA.

Children (Basel). 2018 Aug 31;5(9). pii: E119. doi: 10.3390/children5090119. Review.

5.

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome.

Cowan M, Suntum T, Olivas AD, Perpich M, Applebaum MA, Lastra RR, Yamada SD.

Gynecol Oncol Rep. 2018 Jun 15;25:94-97. doi: 10.1016/j.gore.2018.06.008. eCollection 2018 Aug.

6.

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Maris JM, Diskin SJ, Onel K, Cohn SL.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx093.

7.

Emerging and investigational therapies for neuroblastoma.

Applebaum MA, Desai AV, Glade Bender JL, Cohn SL.

Expert Opin Orphan Drugs. 2017;5(4):355-368. doi: 10.1080/21678707.2017.1304212. Epub 2017 Mar 17.

8.

What Is It? A Rare Presentation of a Meningioma.

Applebaum MA, Barnes C, Harrington M.

Eplasty. 2016 Dec 29;16:e40. eCollection 2016.

9.

An Interesting Case of a Retrobulbar Cavernous Hemangioma.

Applebaum MA, Lee TE, Barnes C, Elston JB, Smith DJ.

Eplasty. 2016 Dec 22;16:ic48. eCollection 2016. No abstract available.

10.

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ.

Eur J Cancer. 2017 Feb;72:177-185. doi: 10.1016/j.ejca.2016.11.022. Epub 2016 Dec 26.

11.

Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.

Applebaum MA, Jha AR, Kao C, Hernandez KM, DeWane G, Salwen HR, Chlenski A, Dobratic M, Mariani CJ, Godley LA, Prabhakar N, White K, Stranger BE, Cohn SL.

Oncotarget. 2016 Nov 22;7(47):76816-76826. doi: 10.18632/oncotarget.12713.

12.

Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.

Doepker MP, Yamamoto M, Applebaum MA, Patel NU, Jaime Montilla-Soler M, Sarnaik AA, Wayne Cruse C, Sondak VK, Zager JS.

Ann Surg Oncol. 2017 Feb;24(2):355-361. doi: 10.1245/s10434-016-5590-8. Epub 2016 Sep 22.

13.

Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?

Doepker MP, Thompson ZJ, Fisher KJ, Yamamoto M, Nethers KW, Harb JN, Applebaum MA, Gonzalez RJ, Sarnaik AA, Messina JL, Sondak VK, Zager JS.

Ann Surg Oncol. 2016 Jul;23(7):2336-42. doi: 10.1245/s10434-016-5167-6. Epub 2016 Mar 8.

14.

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.

Pinto N, Mayfield JR, Raca G, Applebaum MA, Chlenski A, Sukhanova M, Bagatell R, Irwin MS, Little A, Rawwas J, Gosiengfiao Y, Delattre O, Janoueix-Lerosey I, Lapouble E, Schleiermacher G, Cohn SL.

Pediatr Blood Cancer. 2016 Jun;63(6):1019-23. doi: 10.1002/pbc.25934. Epub 2016 Feb 10.

15.

Nasal Tip Reconstruction Using Integra Bilayer Wound Matrix: An Alternative to the Forehead Flap.

Applebaum MA, Daggett JD, Carter WL.

Eplasty. 2015 Dec 2;15:e52. eCollection 2015.

16.

Change in Body Mass Index After Breast Reconstruction and Associated Complications.

Applebaum MA, Miller BT, Lopez J, Doren EL, Laronga C, Smith PD.

Eplasty. 2015 Sep 28;15:e43. eCollection 2015.

17.

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL.

J Clin Oncol. 2015 Sep 20;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. Epub 2015 Aug 24. Review.

18.

Surveillance of Childhood Cancer Survivors: A Lifelong Affair.

Applebaum MA, Cohn SL.

J Clin Oncol. 2015 Nov 1;33(31):3531-2. doi: 10.1200/JCO.2015.62.7703. Epub 2015 Aug 10. No abstract available.

PMID:
26261248
19.

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL.

Pediatr Blood Cancer. 2015 Jan;62(1):128-33. doi: 10.1002/pbc.25249. Epub 2014 Sep 23.

20.

Radiation-induced apoptosis varies among individuals and is modified by sex and age.

Applebaum MA, Skol AD, Bond EE, Overholtzer M, Bond GL, Onel K.

Int J Radiat Biol. 2014 Oct;90(10):903-8. doi: 10.3109/09553002.2014.925603. Epub 2014 Jun 25.

21.

Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

Applebaum MA, Thomas DG, Hembrough T, Burrows J, Horvai AE, Lawlor ER, DuBois SG.

Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):593-9. doi: 10.1097/PAI.0b013e3182a8d4bb.

22.

Perception of transition readiness and preferences for use of technology in transition programs: teens' ideas for the future.

Applebaum MA, Lawson EF, von Scheven E.

Int J Adolesc Med Health. 2013;25(2):119-25. doi: 10.1515/ijamh-2013-0019.

PMID:
23740658
23.

Clinical features and outcomes in patients with secondary Ewing sarcoma.

Applebaum MA, Goldsby R, Neuhaus J, DuBois SG.

Pediatr Blood Cancer. 2013 Apr;60(4):611-5. doi: 10.1002/pbc.24251. Epub 2012 Jul 27.

24.

Evaluation of plasma annexin V levels in children and young adults with solid tumors.

Applebaum MA, Sambrano E, Lee S, Goldsby R, Matthay KK, DuBois SG.

Int J Biol Markers. 2012 Jul 19;27(2):e164-6. doi: 10.5301/JBM.2012.9288. No abstract available.

25.

Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

Applebaum MA, Goldsby R, Neuhaus J, DuBois SG.

Pediatr Blood Cancer. 2012 Oct;59(4):617-20. doi: 10.1002/pbc.24053. Epub 2011 Dec 19.

26.

Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey.

Lawson EF, Hersh AO, Applebaum MA, Yelin EH, Okumura MJ, von Scheven E.

Pediatr Rheumatol Online J. 2011 Dec 6;9(1):35. doi: 10.1186/1546-0096-9-35.

27.

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG.

Cancer. 2011 Jul 1;117(13):3027-32. doi: 10.1002/cncr.25840. Epub 2011 Jan 10.

Supplemental Content

Loading ...
Support Center